Skip to main content
Indoco Remedies Ltd. logo

Indoco Remedies Ltd. — Investor Relations & Filings

Ticker · INDOCO ISIN · INE873D01024 LEI · 3358007XE9RRPHJA6U47 BSE.NS Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2022-08-22 AGM Information
Country IN India
Listing BSE.NS INDOCO

About Indoco Remedies Ltd.

https://www.indoco.com/

Indoco Remedies Ltd. is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of finished dosages and Active Pharmaceutical Ingredients (APIs). The company operates multiple manufacturing facilities equipped to produce various dosage forms, including tablets, capsules, injectables, ophthalmics, and topical preparations. Its therapeutic portfolio spans stomatologicals, anti-infectives, respiratory, cardiovascular, anti-diabetics, and pain management. Indoco maintains a significant global footprint, exporting products to over 55 countries, including highly regulated markets such as the United States and Europe. The organization is recognized for its strong research and development capabilities, focusing on complex generics and niche formulations. Key brands include Sensodent-K, Febrex Plus, and Cyclopam, reflecting its leadership in specific therapeutic segments.

Recent filings

Filing Released Lang Actions
Annual General Meeting
AGM Information Classification · 100% confidence The document is a detailed notice of the 75th Annual General Meeting (AGM) of Indoco Remedies Limited. It includes the schedule of the AGM, agenda items such as adoption of audited financial statements for the fiscal year ended March 31, 2022, dividend declaration, appointment and re-appointment of directors and auditors, and approval of employee stock option plans. The document is addressed to stock exchanges and shareholders, and it is a formal notice inviting shareholders to the AGM with detailed resolutions to be voted on. It does not contain the actual financial statements or detailed financial analysis but rather the notice and agenda for the meeting where such reports will be considered. Therefore, this document fits the category of AGM Information (AGM-R) as it is the official notice and materials shared for the Annual General Meeting.
2022-08-22 English
Newspaper Advertisements
Regulatory Filings
2022-08-22 English
Record Date
Notice of Dividend Amount Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding the book closure and record date for payment of dividend and the Annual General Meeting (AGM). It mentions the dividend recommended by the Board of Directors and the schedule for the AGM. The document does not contain financial statements or detailed financial data but rather announces dates and procedural information related to the AGM and dividend payment. It also includes information about remote e-voting cutoff date for shareholders. The document length is 3075 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Notice of Dividend Amount (DIV) as it announces dividend payment details and related dates, and also includes AGM-related scheduling information. It is not a full Annual Report, Earnings Release, or Proxy Solicitation. Hence, the best classification is DIV with high confidence.
2022-08-22 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the schedule of an upcoming Analyst / Institutional Investors Meeting. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The content is purely an announcement of a meeting schedule, with no financial data, report, or detailed presentation included. The document length is only 1282 characters, indicating it is a brief notice rather than a full report or transcript. Therefore, it fits best under the category of Investor Presentation announcements or meeting schedule notifications. However, since it is only a schedule notification and not the presentation itself, the closest fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2022-08-22 English
Agreements/Contracts/Arrangements/ MOU's PARA B
Capital/Financing Update Classification · 95% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding the execution of Share Purchase and Shareholders' Agreement and Power Purchase Agreement for acquiring a 26% stake in Jalansar Wind Energy Private Limited. It includes detailed annexures describing the parties involved, purpose, shareholding, terms of the agreement, and other disclosures as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content focuses on a transaction related to acquisition and shareholding changes, specifically the acquisition of a stake in another company. There is no financial report, earnings data, or management discussion. The document is a regulatory announcement about a capital transaction and acquisition activity. According to the filing definitions, this fits best under Capital/Financing Update (CAP) as it updates on company fundraising and capital structure changes through acquisition of shares in another entity.
2022-08-16 English
Agreements/Contracts/Arrangements/ MOU's PARA B
Capital/Financing Update Classification · 95% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding the execution of Share Purchase and Shareholders' Agreement and Power Purchase Agreement for acquiring a 26% stake in Kanakal Wind Energy Private Limited. It includes detailed annexures describing the parties involved, purpose, shareholding, terms, and background of the acquisition. The document is a regulatory disclosure under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which mandates disclosure of material events. The content focuses on acquisition and investment details rather than financial results, management changes, or other report types. It is not a full financial report, earnings release, or management discussion. The document is a formal announcement of a capital investment transaction and acquisition of stake in another company. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (7973 characters) supports it being a detailed announcement rather than a brief notice or report publication announcement.
2022-08-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.